05.01.02
Lescarden, New York, NY, has been awarded a patent for its product Poly-NAG® as a treatment for osteoarthritis. The product, derived from shellfish chitin, is a specially processed short chain polymer of glucosamine. The patent (No. 6,117,851), entitled “The Treatment of Osteoarthritis by Administering Poly-N-acetyl-D-glucosamine,” was awarded based on two clinical trials examining bioavailability and product efficacy.